メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
藤田医科大学でコンテンツを検索
ホーム
プロファイル
研究部門
研究成果
Scopus著者プロファイル
大槻 雄士
腫瘍医学研究センター
h-index
266
被引用数
6
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2016
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(12)
類似のプロファイル
(4)
フィンガープリント
Yuji Otsukiが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Aortic Aneurysm
37%
Aldehyde
6%
Amino Acid
7%
Anaplastic Lymphoma Kinase Inhibitor
6%
Angina Pectoris
37%
Anticarcinogen
6%
Antioxidant
7%
Antiporter
7%
Benzaldehyde
37%
Benzaldehyde Derivative
6%
Biological Marker
32%
Cancer Mortality
6%
Carcinoma
74%
CD44v Antigen
14%
Chemotherapy
43%
Combination Therapy
12%
Cysteine
7%
Cystine
7%
Cytotoxicity
14%
Cytotoxicity
6%
Epidermal Growth Factor Receptor
6%
Everolimus
12%
Glutamate Dehydrogenase
22%
Glutamic Acid
14%
Glutamine
22%
Glutathione
7%
Granulation Tissue
37%
Head and Neck Squamous Cell Carcinoma
37%
Histone H3
6%
Immunotherapy
6%
Inflammation
37%
Ischemia
37%
Lung Cancer
37%
Lung Metastasis
6%
Malignant Neoplasm
92%
Mammalian Target of Rapamycin Inhibitor
12%
Necrosis
37%
Neoplasm
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
12%
Ovary Cancer
37%
Oxyfedrine
37%
Pancreas Cancer
6%
Pancreas Tumor
6%
Reactive Oxygen Metabolite
7%
Recurrent Disease
6%
Stomach Cancer
37%
Sulfasalazine
29%
Trametinib
40%
Tricarboxylic Acid
7%
Tumor Growth
8%
Medicine and Dentistry
Abdominal Aortic Aneurysm
12%
Amino Acid Transport
9%
Angina Pectoris
12%
Antioxidant
9%
Antiporter
9%
Artery
12%
Biological Marker
9%
Cancer
12%
Cancer Cell
18%
Cancer Therapy
18%
Carcinoma
37%
Catheter Ablation
9%
CD44v Antigen
18%
Cell Differentiation
9%
Cholecystectomy
12%
Citric Acid Cycle
9%
Cleft
12%
Cysteine
9%
Cystine
9%
Cytotoxicity
18%
Embolization
37%
Fallopian Tube
9%
Fallopian Tube Epithelium
37%
Glutamate Dehydrogenase
27%
Glutamic Acid
18%
Glutamine
27%
Glutathione
9%
Granulation Tissue
12%
Head and Neck Squamous Cell Carcinoma
37%
Hemodialysis
37%
Ischemia
12%
Lobectomy
18%
Lung Cancer
37%
Malignant Neoplasm
9%
Mediastinal Lymph Node
6%
Metabolome Analysis
9%
Mitochondrial Respiration
9%
Necrosis
12%
Neoplasm
21%
Overall Survival
6%
Oxidative Stress
9%
Pneumonectomy
18%
Reactive Oxygen Species
9%
Salazosulfapyridine
37%
Segmentectomy
18%
Squamous Cell Carcinoma Cell
9%
Surgery
12%
Survival Rate
6%
Targeted Therapy
37%
Video-Assisted Thoracoscopic Surgery
37%
Keyphrases
Abdominal US
7%
Aldehyde Metabolism
37%
Angina Pectoris
7%
Benzaldehyde
37%
Bone Therapeutics
6%
Carcinoma
37%
Cellular Antioxidant
7%
Cholecystectomy
7%
Cholesterol Clefts
7%
Cholesterol Crystal Embolism
37%
Covalent Inhibitor
7%
Cysteine Content
9%
Dehydrogenase Enzyme
7%
Developmental Dynamics
7%
Drug Screen
6%
Epithelial Plasticity
37%
Fallopian Tube Epithelium
37%
Ferroptosis Resistance
37%
Fibrin
7%
Gallbladder
37%
Glutaminolysis
37%
Granulation Tissue
7%
GSH Content
9%
Homologous Recombination Proficient
12%
Hypertension Management
7%
In Cancer
37%
In Vivo Environment
6%
Inflammation
7%
Inner Wall
7%
Ischemia
7%
Kit Ligand
37%
Leucophore
13%
Malignancy
7%
Metastasis
12%
Muscular Layer
7%
Necrosis
7%
Needle-like
7%
Older Men
7%
Pathological Examination
7%
Pneumonectomy
7%
Progressive Resistance
12%
PubMed
7%
Redox Status
7%
Ruptured Abdominal Aortic Aneurysm (rAAA)
7%
Small Arteries
7%
Stress Therapy
9%
Systematic Mediastinal Lymph Node Dissection
9%
Trametinib
37%
Treatment Resistance
37%
Tumor
7%
